Total Endovascular Aortic Arch Re-construction Study(TEARS)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

ClinicalTrials.gov Identifier: NCT01496833

Recruitment Status : Recruiting

First Posted : December 21, 2011

Last Update Posted : January 1, 2016

See Contacts and Locations

Sponsor:

Information provided by (Responsible Party):

Xijing Hospital

Study Description

Brief Summary:

The purpose of this study is to investigate the short to mid term efficacy and safety of a newly-developed branched stent graft in patients who had complex aortic lesions, such as ascending aortic/arch aneurysm, pseudo-aneurysm, Stanford Type A dissection, retrograde Stanford Type B dissection, dissection with primary tear located in the aortic arch, et al.

Condition or disease	Intervention/treatment	Phase
Aorta Dissection Aorta Aneurysm	Device: Ankura Branched/Fenestrated Stent Graft	Not Applicable

Detailed Description:

Aneurysms and dissection involving the ascending aorta and aortic arch have historically been treated with open surgical techniques, requiring cardiopulmonary bypass and deep hypothermic circulatory arrest (DHCA). Despite increasing experience and refinement of these procedures, there remains a substantial rate of morality and morbidity. Total endovascular aortic arch and ascending aorta repair is one of the ultimate solutions of these diseases. However, this approach requires extensive technique and new device development. The goal of total endoluminal stent grafting is to re-construct the ascending aorta and aortic arch to cover the primary entry tear of the dissection and to remodel the aorta.Recently, branch and fenestrated stent-grafts has been developed to treat complex ascending and aortic arch disease, which was previously considered to be contraindicated for endovascular repair. This study aims to investigate the short to mid term efficacy and safety of a newly-developed branched stent graft in patients who had complex aortic lesions, such as ascending aortic/arch aneurysm, pseudo-aneurysm, Stanford Type A dissection, retrograde Stanford Type B dissection, dissection with primary tear located in the aortic arch, et al.

Primary outcome measure is all-cause mortality. Secondary outcome variables include conversion to stent and/or surgery, induced thrombosis of the false lumen, cardiovascular morbidity, aortic expansion (>5 mm/y of maximum diameter including true and false lumina), quality of life, and length of intensive care unit and hospital stay. The study designs to enroll 50 patients to be monitored for 24 months.

Study Design


Study Type :	Interventional (Clinical Trial)
Estimated Enrollment :	50 participants
Intervention Model:	Single Group Assignment
Masking:	Single (Participant)
Primary Purpose:	Treatment
Official Title:	Total Endovascular Aortic Arch Re-construction Study(TEARS)------China's Registry
Study Start Date :	January 2015
Estimated Primary Completion Date :	December 2018
Estimated Study Completion Date :	December 2018

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Aneurysms Plastic and Cosmetic Surgery Tears

U.S. FDA Resources

Arms and Interventions

Arm	Intervention/treatment
Experimental: Endovascular Total endovascular arch reconstruction	Device: Ankura Branched/Fenestrated Stent Graft Ankura Branched/Fenestrated Stent Graft（Lifetech Scientific Co.,LTD.，Shenzhen, China） Other Names: Ankura-TM Stent Graft Ankura Branched Stent Graft Ankura Fenestrated Stent Graft

Outcome Measures

Primary Outcome Measures :

cumulative MACE (including death, rupture, paraplegia, aneurysm formation) [ Time Frame: 12 months ]

Secondary Outcome Measures :

Endoleak [ Time Frame: 12 months ]
Endoleak of all types
Stent-graft migration/kinking [ Time Frame: 12 months ]
Stent-graft migration, stenosis, kinking and other conditions requiring re-intervention
cumulative cerebrovascular events [ Time Frame: 12 months ]
cumulative cerebrovascular events

Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:	12 Years to 90 Years (Child, Adult, Older Adult)
Sexes Eligible for Study:	All
Accepts Healthy Volunteers:	No

Criteria

Inclusion Criteria:

Ascending aortic/arch aneurysm
Ascending aortic/arch pseudo-aneurysm
Stanford Type A dissection
Retrograde Stanford Type B dissection
Unclassified dissection with primary tear located in the aortic arch
Able to tolerate endotracheal intubation and general anesthesia
Subject's anatomy must meet the anatomical criteria to receive that implanted device
The subject or legal guardian understands the nature of the study and agrees to its provisions on a written informed consent form
Availability for the appropriate follow-up visits during the follow-up period
Capability to follow all study requirements

Exclusion Criteria:

ASA classification = V
Severe renal insufficiency defined as SVS risk renal status = 3
Severe respiratory insufficiency defined as SVS risk pulmonary status = 3
Presence of connective tissue disease
Active infection or active vasculitides
Pregnant woman or positive pregnancy test
Myocardial infarction or cerebrovascular accident within 6 weeks prior to study enrollment
Subject has had a cerebral vascular accident (CVA) within 2 months.
History of drug abuse
Subject has a history of bleeding diathesis, coagulopathy, or refuses blood transfusion.
Subject has a known allergy or intolerance to the device components.
Subject has a known hypersensitivity or contraindication to anticoagulants or contrast media, which is not amenable to pre-treatment.
Subject has a co-morbidity causing expected survival to be less than 1 year.
Enrolment in another clinical study
Unwillingness to cooperate with study procedures or follow-up visits

Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01496833

Contacts


Contact: Jian Yang, MD,PhD	86-13892828016	yangjian1212@hotmail.com

Locations


China, Shaanxi
Department of Cardiovascular Surgery of Xijing Hospital, Fourth Military Medical University	Recruiting
Xi'an, Shaanxi, China, 710032
Contact: Jian Yang, MD,PhD

Sponsors and Collaborators

Xijing Hospital

Investigators


Principal Investigator:	Jian Yang, MD,PhD	Department of Cardiovascular Surgery of Xijing Hospital, Fourth Military Medical University
Study Chair:	Dinghua Yi, M.D., PhD.	Department of Cardiovascular Surgery of Xijing Hospital, Fourth Military Medical University

More Information


Responsible Party:	Xijing Hospital
ClinicalTrials.gov Identifier:	NCT01496833 History of Changes
Other Study ID Numbers:	XJ-20111126
First Posted:	December 21, 2011 Key Record Dates
Last Update Posted:	January 1, 2016
Last Verified:	December 2015

Keywords provided by Xijing Hospital:


Aortic Diseases Vascular Diseases Cardiovascular Diseases Treatment Outcome	Aorta Dissection Aorta Aneurysm Aorta pseudoaneurysm Endovascular aortic repair

Additional relevant MeSH terms:


Aneurysm Aortic Aneurysm Vascular Diseases Cardiovascular Diseases Aortic Diseases

To Top